]>
IRCT20180926041146N1 IRCT 2018-11-10 Shahid Beheshti University of Medical Sciences Effect of vitamin D on maintaining immunity level in HIV patients Assessing the effect of vitamin D on the CD4 count and some blood indices in Human Immunodeficiency Virus (HIV) patients 2016-06-20 anticipated 66 Complete https://irct.ir/trial/34248 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: At first, by simple random sampling, the names of all people met the inclusion criteria were listed in the list of registered individuals at the specialist offices of the counseling center. After examining their files, their phone numbers and addresses were extracted. They were contacted and if they were enrolled to the study, if they were willing to cooperate and participate. Individuals were randomly entered the intervention and control groups. In this way, the cards with numbers 1 and 2 were prepared; the code of one was related to intervention as compared to the code of two for control group. These cards were placed in a thick envelope, and patients in the first stage of sampling, when they went to each, chose a card, and they were placed in the corresponding group. 4 HIV. Intervention group: A Perl of 50,000 units of vitamin D3 was orally administered per month. Then, three and six months after the intervention, the questionnaire was again filled up for the complete research samples and the tests contained therein.. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Still, the release of individual data has not been identified and will be decided upon completion of the study.
public Zohreh Haghighatdana
Next to the municipality, Shahid Beheshti Ave.
Varamin Iran (Islamic Republic of) 3371664339 +98 21 3624 2937 Haghighatz@yahoo.com Shahid Beheshti University of Medical Sciences scientific Zohreh Haghighatdana
Next to the municipality, Shahid Beheshti Ave.
Varamin Iran (Islamic Republic of) 3371664339 +98 21 3624 2937 haghighatz@yahoo.com Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Age older than 18 years Non-pregnant women Intervals of at least 6 months since the start of the last regimen Not taking vitamin supplements at least three months before the start of the study No diseases and acute problems preventing intervention by taking vitamin D3 Lack of psychological illnesses and willingness to cooperate in this research project 18 years no limit Both Modifying the antiretroviral therapy during the study Getting pregnancy in female patients The absence of referral patients for monthly supplementation of vitamin D3 even for one month The occurrence of any illness or specific problem during the conduct of the research People with sarcoidosis, hyperparathyroidism, kidney disease and histoplasmosis B23.2 HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified Treatment - Drugs Intervention group: A Perl of 50,000 units of vitamin D3 was orally administered per month. Then, three and six months after the intervention, the questionnaire was again filled up for the complete research samples and the tests contained therein. CD4 Cells Count. Timepoint: Before intervention, three and six months after intervention. Method of measurement: Blood Test. Complete Blood Count. Timepoint: Before intervention, three and six months after the intervention. Method of measurement: Blood Test. Shahid Beheshti University of Medical Sciences Approved 2018-08-13 Ethics committee of Shahid beheshti University of Medical Sciences Next to Ayatollah Taleghani Hospital, Shahid Erabi Ave., Yeman Blvd., Shahid Chamran Highway Tehran Tehran Iran (Islamic Republic of)